knowledge -WSS

knowledge

author：Wikipedia 2025-09-03 03:33:00 - browse：4531

Illustration of a red human heart with an EKG line in the middle. -- health coverage from STAT — Adobe

Just weeks after Novo Nordisk announced that its obesity drug Wegovy cut the risk of heart complications in a major trial, the company now has results from a different study showing the treatment can also benefit people with a common type of heart failure.

The results, published Friday in the New England Journal of Medicine, found that among people with obesity and heart failure with preserved ejection fraction, or HFpEF, those taking Wegovy experienced greater improvements in symptoms and physical function compared with those on placebo. The improvements were greater than what’s been seen in trials of some other HFpEF treatments.

Novo previously shared topline results in investor calls, but the new study contains the full findings, which are also being presented at the European Society of Cardiology conference this week.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： CDC: Uninsured rate hit 'record low' right as states cut Medicaid

WSS

'Ancient DNA,' 23andMe reveal African American ancestries

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Some medical students still think black patients feel less pain

What the cancer research community can learn from the Covid response

2 US Navy sailors arrested for allegedly spying for China

focus

knowledge

entertainment

Hepatitis C has a cure — but many Americans still lack access to it

Ozempic cut risk of death in diabetes patients with chronic kidney disease

In age of alternative facts, a scholarly course on calling out crap

Attacks on the drug industry will lead to fewer breakthroughs

Medical leaders decry Supreme Court decision on affirmative action

Medical students need to learn the potent medicine of empathy

In age of alternative facts, a scholarly course on calling out crap

Stem cell clinics for heart failure: buyer be wary

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

leisure time

New research sheds light on how often breast cancer is overdiagnosed

What Mike Pence has said that could be used in a Donald Trump trial

Medical students need to learn the potent medicine of empathy

Stem cell clinics for heart failure: buyer be wary

Verily hires former Apple Health leader as chief scientific officer

Stroke rates rising, especially in working

hotspot

entertainment

knowledge

entertainment